{"entity":{"id":"nct03579602","kind":"trial","name":"Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery","aka":[],"tldr":"A phase 2/3 trial of Tozuleristide run by Blaze Bioscience Inc., completed.","summary":"Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery is a phase 2/3 interventional study registered as NCT03579602 by Blaze Bioscience Inc., with 118 participants enrolled, started 2018-11-26. Conditions recorded: Pediatric Central Nervous System Tumor. Interventions recorded: tozuleristide and Canvas System.","status":"completed","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT03579602","url":"https://clinicaltrials.gov/study/NCT03579602"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["brain-tumours"],"sections":[],"technologies":[],"targets":[],"drugs":["blz-100"],"companies":["blaze-bioscience"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT03579602","phase":"2/3","setting":"A Randomized, Blinded Study of Fluorescence Detection of Pediatric Primary Central Nervous System Tumors in Subjects Receiving Tozuleristide and Imaged With the Canvas System","sponsor":"Blaze Bioscience Inc.","enrolled":118,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct03579602/","neighbours":{"cancer":[{"id":"brain-tumours","kind":"cancer","name":"Brain and spinal cord tumours (all types)","route":"/cancers/brain-tumours/"}],"drug":[{"id":"blz-100","kind":"drug","name":"Tozuleristide","route":"/drugs/blz-100/"}],"company":[{"id":"blaze-bioscience","kind":"company","name":"Blaze Bioscience","route":"/companies/blaze-bioscience/"}]}}